UnitedHealth Group Inc. (NYSE:UNH)

An examination of short-term operating activity ratios reveals several trends between 2021 and 2025. The receivables turnover generally decreased from 2021 to 2023, then exhibited a slight recovery in the subsequent two years. Conversely, payables turnover demonstrated a modest, consistent increase throughout the period. The average receivable collection period lengthened from 18 days in 2021 to 21 days in 2023, before decreasing to 19 days in 2025. The average payables payment period also increased initially, peaking at 50 days in 2022, but then decreased consistently to 46 days in 2025.

Receivables Turnover

Receivables turnover decreased from 20.07 in 2021 to 17.27 in 2023, indicating a lengthening of the time it takes to collect on credit sales. However, a slight improvement occurred in 2024 and 2025, with turnover reaching 17.66 and 19.27 respectively. This suggests a potential stabilization or modest improvement in collection efficiency towards the end of the period.

Payables Turnover

Payables turnover experienced a steady increase from 7.63 in 2021 to 7.98 in 2025. This indicates that the company is becoming more efficient in paying its suppliers, or is taking advantage of extended payment terms. The increase, while consistent, is relatively small.

Average Collection Period

The average receivable collection period increased from 18 days in 2021 to 21 days in 2023, suggesting a slower collection process. The period then decreased to 19 days in 2025, potentially reflecting improved collection efforts or a change in customer payment behavior. Overall, the period remained relatively stable, fluctuating within a narrow range.

Average Payment Period

The average payables payment period increased from 48 days in 2021 to 50 days in 2022, then decreased consistently to 46 days in 2025. This suggests an initial lengthening of payment terms to suppliers, followed by a return to more prompt payments. The trend could be influenced by supplier negotiations or changes in the company’s cash flow management.

The observed trends suggest a dynamic relationship between the company’s collection and payment practices. While receivables collection slowed initially, it showed signs of improvement in the later years. Simultaneously, the company demonstrated an ability to manage its payables, initially extending payment terms and then gradually reducing the payment period.

An examination of the provided financial information reveals trends in receivables turnover over a five-year period. Revenues demonstrated consistent growth throughout the period, increasing from US$285,273 million in 2021 to US$443,647 million in 2025. Accounts receivable, net of allowances, also increased over the same timeframe, albeit at a slower rate, rising from US$14,216 million in 2021 to US$23,018 million in 2025.

Receivables Turnover Trend

The receivables turnover ratio exhibited a generally decreasing trend from 2021 to 2023, declining from 20.07 to 17.27. This suggests a lengthening of the average collection period for accounts receivable during these years. A slight increase was observed in 2024, with the ratio reaching 17.66, followed by a more pronounced increase to 19.27 in 2025. This recent improvement indicates a potential shortening of the collection period.

Relationship to Revenue Growth

Despite the overall revenue growth, the initial decline in receivables turnover suggests that the company’s ability to efficiently convert receivables into cash was diminishing in the early part of the period. The subsequent recovery in 2024 and 2025, coupled with continued revenue growth, indicates improved efficiency in managing accounts receivable. However, the ratio in 2025 remains below the level observed in 2021.

Accounts Receivable Growth vs. Turnover

The growth rate of accounts receivable was consistently lower than the growth rate of revenues. This difference contributed to the initial decline in receivables turnover. The continued growth in receivables, even with improving turnover in the later years, suggests that a larger absolute dollar amount is tied up in receivables compared to earlier periods, despite more efficient collection efforts.

In summary, while the receivables turnover ratio demonstrates a recent positive trend, the overall pattern suggests a need for continued monitoring of accounts receivable management practices to ensure alignment with revenue growth and maintain optimal cash flow efficiency.

The analysis reveals a generally increasing trend in medical costs and associated payables over the five-year period. Concurrently, the payables turnover ratio exhibits a modest upward trajectory, suggesting a slight improvement in the efficiency of managing payments related to medical expenses.

Medical Costs

Medical costs demonstrate a consistent year-over-year increase, rising from US$186,911 million in 2021 to US$313,995 million in 2025. This represents a substantial cumulative growth, indicating an expansion in healthcare service provision or increasing costs per service.

Medical Costs Payable

Medical costs payable also increase steadily throughout the period, moving from US$24,483 million in 2021 to US$39,337 million in 2025. While growing, the increase in payables is proportionally less than the increase in medical costs, which is reflected in the payables turnover ratio.

Payables Turnover

The payables turnover ratio fluctuates slightly but generally trends upward, beginning at 7.63 in 2021, decreasing to 7.26 in 2022, then increasing to 7.98 in 2025. This indicates that, on average, the company is becoming slightly more efficient in paying its medical suppliers over time. The dip in 2022 warrants further investigation, but the subsequent recovery and continued increase suggest it was a temporary deviation. A higher ratio implies that the company is paying its suppliers more quickly, potentially benefiting from early payment discounts or maintaining strong supplier relationships. The increase, while not dramatic, suggests improved working capital management related to medical expenses.

In summary, the observed trends suggest a growing business with a stable, and slightly improving, approach to managing payments for medical costs. The consistent growth in both costs and payables is expected for a growing organization, and the increasing payables turnover ratio is a positive indicator of operational efficiency.

The provided financial information details working capital and revenues over a five-year period. Analysis reveals a consistent pattern of negative working capital alongside increasing revenues. The working capital turnover ratio, calculated from these figures, demonstrates a fluctuating trend.

Working Capital

Working capital is consistently negative throughout the observed period, ranging from approximately -US$16.5 billion in 2021 to -US$24.3 billion in 2025. The magnitude of the negative working capital generally increases over time, with a slight decrease observed in 2024 before resuming an upward trend in 2025. This indicates the company consistently finances its operations with more liabilities than liquid assets.

Revenues

Revenues exhibit a consistent upward trend, increasing from US$285.3 billion in 2021 to US$443.6 billion in 2025. The rate of revenue growth appears relatively stable year-over-year, suggesting consistent business expansion.

Working Capital Turnover

Due to the negative working capital, the working capital turnover ratio is also negative. The ratio fluctuates, but generally becomes less negative (approaching zero) as revenues increase. A more negative ratio indicates a greater reliance on external financing to support revenue generation. While the absolute value decreases over time, the negative sign persists, reflecting the ongoing negative working capital position. Calculating the ratio for each year yields the following: 2021: -17.25, 2022: -15.98, 2023: -17.80, 2024: -21.96, 2025: -18.23. The most significant shift is observed between 2023 and 2024, where the ratio becomes substantially more negative.

In summary, the company demonstrates strong revenue growth concurrent with a consistently negative working capital position. The working capital turnover ratio, while negative, shows some fluctuation, but generally trends towards a less negative value as revenues increase. The increasing magnitude of negative working capital warrants continued monitoring.

The average receivable collection period exhibited a generally increasing trend from 2021 to 2023, followed by stabilization and a slight decrease. This indicates a lengthening in the time required to collect receivables, then a return towards historical levels.

Average Receivable Collection Period

In 2021, the average receivable collection period was 18 days. This figure increased to 20 days in 2022 and further to 21 days in 2023. The period remained at 21 days in 2024 before decreasing slightly to 19 days in 2025. This suggests a potential slowing in the efficiency of collecting receivables between 2021 and 2023, which then showed signs of improvement in the most recent period.

The receivables turnover ratio, while not the primary focus, provides context. A decreasing receivables turnover from 20.07 in 2021 to 17.27 in 2023 aligns with the increasing collection period, reinforcing the observation of a slower collection process. The ratio then showed a modest recovery in 2024 and 2025, coinciding with the stabilization and slight decrease in the average collection period.

The recent decrease in the average receivable collection period in 2025 could be attributed to improved collection efforts, changes in customer payment terms, or a shift in the composition of receivables. Further investigation would be needed to determine the underlying cause of these fluctuations.

The average payables payment period exhibited a generally decreasing trend over the five-year period. Simultaneously, payables turnover demonstrated a slight upward trajectory. These movements suggest evolving dynamics in the company’s supplier relationships and working capital management.

Payables Turnover

Payables turnover increased from 7.63 in 2021 to 7.98 in 2025. While not a substantial increase, the consistent rise indicates the company is, on average, paying its suppliers more frequently over time. A slight dip occurred in 2022, falling to 7.26, before resuming an upward trend.

Average Payables Payment Period

The average payables payment period began at 48 days in 2021. It increased slightly to 50 days in 2022, representing a longer time to settle obligations. However, the period then decreased consistently, reaching 46 days by 2025. This suggests a strengthening of the company’s ability to manage and potentially reduce the time taken to pay its suppliers. The decrease is relatively modest, indicating a gradual shift rather than a dramatic change in payment practices.

The inverse relationship between payables turnover and the average payables payment period is as expected. As turnover increases, the payment period decreases, and vice versa. The observed trends suggest the company is maintaining a stable, yet slightly improving, relationship with its suppliers, balancing the need for efficient cash management with maintaining positive vendor relations.